Skip to content

Moderna MRNA Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin178.2%-31.1pp210.2%+32.5pp209.6%+55.2pp228.8%+104pp209.4%+60.4pp
Operating margin-573%-189pp-537%-170pp-500.8%-194pp-398.7%-116pp-384.3%-198pp
Net margin-522.6%-138pp-484.8%-86.2pp-449.6%-89.1pp-358.1%-7.6pp-384.2%-166pp
EBITDA margin-535.3%-180pp-503.8%-171pp-472.8%-203pp-373.6%-127pp-355.5%-198pp
Returns
Return on equity-122.2%-2.4pp-115%+14.5pp-114.9%+15.7pp-104.8%+28.6pp-119.8%-35.7pp
Return on assets-91%-0.1pp-87.4%+11.0pp-88%+10.8pp-79.5%+20.7pp-90.9%-28.2pp
Return on invested capital-145.8%-14.7pp-138.4%-6.6pp-138.5%-13.9pp-127.7%-7.1pp-131.1%-51.0pp
Efficiency
Asset turnover0.7×-0.3×0.7×-0.3×0.8×-0.3×0.9×-0.3×-0.4×
Inventory turnover43.4×+4.1×40×+3.4×42.6×+6.4×41.7×+12.6×39.2×+14.3×
Liquidity
Current ratio13.6×-2.8×15.4×-0.8×15.7×-0.2×16.2×+2.2×16.4×+3.1×
Quick ratio13.3×-2.8×15.1×-0.9×15.4×-0.3×15.9×+2.2×16.1×+3.2×
Cash ratio3.6×-0.1×3.8×+0.3×3.4×-0.3×3.5×-0.1×3.7×-0.1×
Leverage
Debt-to-equity0.5×+0.1×0.4×0.0×0.3×-0.1×0.3×-0.1×0.4×0.0×
Debt-to-assets0.4×+0.1×0.3×0.0×0.2×-0.1×0.3×0.0×0.3×0.0×
Per Share
Book value per share$89.14-22.4%$96.46-21.1%$102.61-21.2%$108.58-19.9%$114.86-23.2%
Valuation
Market capitalization$52.08B-46.9%$42.9B-66.5%$47.38B-68.4%$63.02B-61.5%$98.16B-40.3%
Enterprise value$49.35B-47.9%$39.9B-68.0%$44.48B-69.5%$60.23B-62.0%$94.68B-40.1%
Price / sales22.9×+0.4×17.2×-9.7×16.3×-11.3×16.8×-10.0×22.5×+0.4×
Price / book6.2×-2.4×4.6×-6.1×4.7×-7.2×5.8×-6.9×8.6×-3.0×
EV / sales21.6×+0.1×16×-10.1×15.3×-11.5×16×-10.0×21.5×+0.2×
Earnings yield-99.4%-23.6pp-114.1%-53.8pp-111.9%-60.9pp-90.4%-40.0pp-75.8%-41.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Moderna's profit margins?
Moderna (MRNA) runs a 22.1% gross margin and a -153.3% operating margin, with a -143.6% net margin.
Where do Moderna's ratios come from?
Every ratio is computed from Moderna's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.